tiprankstipranks
Advertisement
Advertisement

RLMD Stock Latest News

Relmada Therapeutics Earnings Call Highlights NDV-01 Path
Company AnnouncementsRelmada Therapeutics Earnings Call Highlights NDV-01 Path
2d ago
RLMD
Relmada Highlights Q2 Results and NDV-01 Pipeline Progress
PremiumCompany Announcements
Relmada Highlights Q2 Results and NDV-01 Pipeline Progress
8d ago
8K
RLMD
Relmada Therapeutics reports Q2 EPS (11c), consensus (20c)
PremiumThe Fly
Relmada Therapeutics reports Q2 EPS (11c), consensus (20c)
8d ago
RLMD
Relmada Therapeutics Inc (RLMD) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Relmada Therapeutics Inc (RLMD) Q2 Earnings Cheat Sheet
10d ago
RLMD
Relmada Therapeutics appoints Bipin Dalmia as chief business officer
PremiumThe Fly
Relmada Therapeutics appoints Bipin Dalmia as chief business officer
17d ago
RLMD
Relmada Therapeutics names Bipin Dalmia chief business officer
PremiumThe FlyRelmada Therapeutics names Bipin Dalmia chief business officer
17d ago
RLMD
Relmada Therapeutics Appoints New Chief Business Officer
Premium
Company Announcements
Relmada Therapeutics Appoints New Chief Business Officer
17d ago
8K
RLMD
Relmada Therapeutics joins Russell 2000, Russell 3000 Indexes
Premium
The Fly
Relmada Therapeutics joins Russell 2000, Russell 3000 Indexes
2M ago
RLMD
Relmada Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Relmada Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
RLMD
Relmada Therapeutics Increases Authorized Shares After Shareholder Vote
PremiumCompany Announcements
Relmada Therapeutics Increases Authorized Shares After Shareholder Vote
3M ago
8K
RLMD
Relmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
PremiumCompany Announcements
Relmada Therapeutics Charts Ambitious NDV-01 Phase 3 Path
3M ago
RLMD
Relmada Therapeutics files automatic mixed securities shelf
PremiumThe Fly
Relmada Therapeutics files automatic mixed securities shelf
3M ago
RLMD
Relmada Highlights NDV-01 Phase 2 Data, Phase 3 Plans
PremiumCompany AnnouncementsRelmada Highlights NDV-01 Phase 2 Data, Phase 3 Plans
3M ago
8K
RLMD
Relmada Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Relmada Therapeutics initiated with an Overweight at Piper Sandler
5M ago
RLMD
Relmada Therapeutics Charts Aggressive Path After Earnings Call
Premium
Company Announcements
Relmada Therapeutics Charts Aggressive Path After Earnings Call
5M ago
RLMD
Relmada Highlights NDV-01 Data, Funding in 2025 Results
PremiumCompany Announcements
Relmada Highlights NDV-01 Data, Funding in 2025 Results
5M ago
8K
RLMD
Relmada Therapeutics price target raised to $19 from $10 at Mizuho
PremiumThe Fly
Relmada Therapeutics price target raised to $19 from $10 at Mizuho
5M ago
RLMD
Relmada’s Withdrawn Phase 3 Bladder Cancer Trial: What It Means for RLMD Investors
PremiumCompany Announcements
Relmada’s Withdrawn Phase 3 Bladder Cancer Trial: What It Means for RLMD Investors
5M ago
RLMD
Relmada’s Withdrawn BOOST Trial Resets Expectations for NDV-01 and RLMD
PremiumCompany Announcements
Relmada’s Withdrawn BOOST Trial Resets Expectations for NDV-01 and RLMD
5M ago
RLMD
Relmada Therapeutics Inc (RLMD) Q4 Earnings Cheat Sheet
PremiumPre-EarningsRelmada Therapeutics Inc (RLMD) Q4 Earnings Cheat Sheet
5M ago
RLMD
Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!
5M ago
GE
MU
Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
Premium
The Fly
Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
5M ago
MU
VZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >